Immutep has announced positive phase one trial results for a compound that could help treat autoimmune diseases.

In the past six months alone, shares in this ASX lithium stock have bolted by 162% to $0.34 apiece at the time of writing.

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through ...

Despite the huge gains over the last six months, Mineral Resources shares, Liontown shares, and indeed most all ASX lithium ...

Domino's Pizza dropped nearly 2% as Citi downgraded its shares to a sell, citing challenges in France and Japan and recent ...

The jump has helped to recover some of the fast food retailers' recent share price losses, albeit there is a long way to go ...

At the start of 2025, shares were trading for approximately $14. Last week, shares closed at $26.40, which represents a rise ...

Will owners of Flight Centre Travel Group Ltd (ASX: FLT) shares see profit soar higher? Let’s take a look at the analyst ...

The move implies that management see Reece shares as currently undervalued and the market clearly sees value in Reece backing ...

This ASX All Ords share has more than doubled investors’ money in a year. Here’s why it could keep racing higher in 2026.

DroneShield shares gained attention due to an update on its governance review, addressing issues from recent controversies ...

As demand for artificial intelligence (AI) remains strong, investors are wondering who the biggest winners will be going into ...